Home Antibody All anti-RPS6KA3 antibodies
Anti-RPS6KA3 Antibody Y82
Also for RPS6KA3 (NM_004586)
|A synthetic peptide corresponding to residues in C-terminus of human p90-RSK2 was used as immunogen.|
||0.5~1.0 mg/ml (Lot Dependent)
||WB: 1:1000; IHC-P: Use at an assay dependent dilution; FC: 1:20; IP: 1:50
|PBS 49%,Sodium azide 0.01%,Glycerol 50%,BSA 0.05%|
|Protein A purified
|Is unsuitable for ICC.
|Homo sapiens ribosomal protein S6 kinase, 90kDa, polypeptide 3 (RPS6KA3)|
|CLS; HU-3; ISPK-1; MAPKAPK1B; MRX19; p90-RSK2; pp90RSK2; RSK; RSK2; S6K-alpha3|
|This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS). [provided by RefSeq]. |
EGFR1 Signaling Pathway
MAPK signaling pathway
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot - Rsk 2 / MAPKAP Kinase 1b antibody [Y82]; Anti-Rsk 2 / MAPKAP Kinase 1b antibody [Y82] at 1/1000 dilution + MCF7 cell lysate.Predicted band size : 90 kDa.Observed band size : 90 kDa.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Rsk 2 / MAPKAP Kinase 1b antibody [Y82]; TA303690 at a 1:250 - 1:500 dilution staining Rsk 2 / MAPKAP Kinase 1b in human urinary bladder carcinoma, using Immunohistochemistry, Paraffin Embedded Tissue.